Esmketamine for profound and moderate sedation in pediatric patients.
Phase 4
- Conditions
- Outpatient Child sedation
- Registration Number
- ChiCTR2400088919
- Lead Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) American Society of Anesthesiologists (ASA) grade ?-?; <br>(2) Children aged 0-5 years old; <br>(3) There were no gender restrictions for the subjects; <br>(4) No recent history of sedative usage; <br>(5) Body mass index (BMI) less than 25; <br>(6) No history of mental illness; <br>(7) Legal guardians must provide informed consent for sedation.<br>
Exclusion Criteria
- The family members of the children declined to provide informed consent for their participation in the trial.<br>2) Previous history of allergy to narcotic drugs, active ingredients, and excipients is present.<br>3) Patients with severe congenital heart disease and abnormal liver and kidney function are excluded.<br>4) Children with gastroesophageal reflux are not eligible for inclusion.<br>5) The presence of conscious disturbance is considered an exclusion criterion.<br>6) A history of nervous system disorders and mental illness is taken into account as an exclusion factor.<br>7) Individuals at serious risk of elevated blood pressure or intracranial pressure are excluded from the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method heart rate;oxygen saturation;blood pressure;
- Secondary Outcome Measures
Name Time Method